ED
INSIDER · 2 COMPANIES · DIRECTOR
Epstein David R
Every open-market transaction filed under this name, Sep 1 to Oct 8. The same name appears at more than one issuer; filings don’t say whether it’s one person.
Filings
4
3 buys · 1 sell
Bought
$131K
open market, at cost
Sold
$16K
includes scheduled sales
Buys since
−4.5%
avg move from buy price, 3 priced
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 8 | AGMB | AgomAb Therapeutics NV | Director | Buy | 5,000 | $8.90 | $45K | −6.4% |
| Oct 6 | AGMB | AgomAb Therapeutics NV | Director | Buy | 5,000 | $8.70 | $44K | −4.3% |
| Oct 5 | AGMB | AgomAb Therapeutics NV | Director | Buy | 5,000 | $8.57 | $43K | −2.8% |
| Sep 1 | TEM | Tempus AI, Inc. | Director | Sell | 250 | $65.55 | $16K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.